Skip to NavigationSkip to content

News

British Prime Minister Boris Johnson has tested positive for coronavirus, developing mild symptoms over the last 24 hours which included a...
Teva pharmaceuticals have said they will provide ten million doses of its anti-malaria drug hydroxychloroquine, which President Trump has been...
The increasing spread of the COVID-19 coronavirus pandemic threatens the drug supply lines of the biggest pharmaceutical companies, including...
AbbVie has announce it will not defend its patent to its HIV therapy Kaletra (lopinavir) so it can be made widely available for potential treatment...
The approval covers a range of RMS variants, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive...
The FDA have announced they will allow doctors to use convalescent plasma, collected from people who recovered from COVID-19, to treat those who are...
Japan’s Ministry of Health, Labour and Welfare has awarded approval to AstraZeneca’s Lokelma for the treatment of hyerkalaemia, marking the first...
Gilead Sciences has submitted a request for the FDA to rescind its offer of Orphan Drug designation for remdesivir in treating coronavirus, after a...
Novartis has revealed five-year data on its gene therapy Zolgensma, boasting that the one-time infusion demonstrated “rapid, significant and...
The British government has implemented new restrictions to protect high demand medicines for coronavirus patients.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches